Volume 53, Issue 4 pp. 423-430

Tall stature in familial glucocorticoid deficiency

Lucila L. K. Elias

Lucila L. K. Elias

Departments of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK,

Search for more papers by this author
Angela Huebner

Angela Huebner

Children's Hospital, Technical University Dresden, Dresden, Germany,

Search for more papers by this author
Louise A. Metherell

Louise A. Metherell

Departments of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK,

Search for more papers by this author
Atilio Canas

Atilio Canas

Department of Paediatric Endocrinology, Winthrop University Hospital, Mineola, NY, USA,

Search for more papers by this author
Gary L. Warne

Gary L. Warne

Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia,

Search for more papers by this author
Maria L Manca Bitti

Maria L Manca Bitti

Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia,

Search for more papers by this author
Stefano Cianfarani

Stefano Cianfarani

Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia,

Search for more papers by this author
Peter E. Clayton

Peter E. Clayton

Endocrine Sciences Research Group, Department of Medicine, University of Manchester, Manchester, UK

Search for more papers by this author
Martin O. Savage

Martin O. Savage

Departments of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK,

Search for more papers by this author
Adrian J. L. Clark

Adrian J. L. Clark

Departments of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK,

Search for more papers by this author
First published: 24 December 2001
Citations: 77
Professor Adrian J. L. Clark, Department of Chemical Endocrinology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. Fax: +44 (0) 20 7601 8468; E-mail: [email protected]

Abstract

OBJECTIVE

Familial glucocorticoid deficiency (FGD) has frequently been associated with tall stature in affected individuals. The clinical, biochemical and genetic features of five such patients were studied with the aim of clarifying the underlying mechanisms of excessive growth in these patients.

PATIENTS AND METHODS

Five patients with a clinical diagnosis of FGD are described in whom the disorder resulted from a variety of novel or previously described missense or nonsense mutations of the ACTH receptor (MC2-R). All patients demonstrated excessive linear growth over that predicted from parental indices and increased head circumference.

RESULTS

Growth hormone and IGF-I-values were normal. Growth charts suggest that the excessive growth is reduced to normal following the introduction of glucocorticoid replacement. A characteristic facial appearance including hypertelorism, marked epicanthic folds and prominent frontal bossing was noted.

CONCLUSIONS

These findings indicate that ACTH resistance resulting from a defective ACTH receptor may be associated with abnormalities of cartilage and/or bone growth independently of the GH–IGF-I axis, but probably dependent on ACTH actions through other melanocortin receptors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.